REQUEST A DEMO
Total
USD $0.00
Search more companies

Taiwan Bio Therapeutics Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Taiwan Bio Therapeutics Co., Ltd. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Taiwan Bio Therapeutics Co., Ltd. is a pharmaceutical company in engineered cell therapy new drug development. The company’s main products include “Total solution” CDMO/CMO services for cell therapy products. The company was established in 2014 and is headquartered in Hsinchu County, Taiwan.

Headquarters
4F., No. 66, Shengyi 2Nd Rd
Zhubei City;

Contact Details: Purchase the Taiwan Bio Therapeutics Co., Ltd. report to view the information.

Website: http://www.twbio-thera.com

Basic Information
Total Employees:
Purchase the Taiwan Bio Therapeutics Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Taiwan Bio Therapeutics Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Taiwan Bio Therapeutics Co., Ltd. report to view the information.
Incorporation Date:
July 25, 2014
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Operating Officer
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
10.2%
Purchase this report to view the information.
9.82%
Purchase this report to view the information.
5.81%
Purchase this report to view the information.
1.19%
Purchase this report to view the information.
Subsidiaries
TRANSFORMATIVE CELL PROCESSING CO., Ltd.
16.53%
Company Performance
Financial values in the chart are available after Taiwan Bio Therapeutics Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-62.21%
Total operating revenue
-62.21%
Operating profit (EBIT)
-41.39%
EBITDA
-43.68%
Net Profit (Loss) for the Period
-39.19%
Total assets
11.53%
Total equity
16.22%
Operating Profit Margin (ROS)
-742.42%
Net Profit Margin
-746.8%
Return on Equity (ROE)
-2.96%
Quick Ratio
-1.31%
Cash Ratio
-1.32%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?